Michael King, MD
Allergy & Immunology · Trumbull, CTNPI 1861434086
Payments from drug & device makers
Across 600 payments — averaging $22.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$2K
- AstraZeneca$2K
- CSL Behring$2K
- GSK$2K
- Pfizer$790
- Regeneron Healthcare Solutions, Inc.$689
- plus $4K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 95 | $2,223 |
| AstraZeneca | 57 | $2,030 |
| CSL Behring | 98 | $1,936 |
| GSK | 87 | $1,595 |
| Pfizer | 38 | $790 |
| Regeneron Healthcare Solutions, Inc. | 34 | $689 |
| Genentech USA, Inc. | 30 | $638 |
| Takeda Pharmaceuticals U.S.A., Inc. | 25 | $573 |
| Pharming Healthcare, Inc. | 12 | $452 |
| Biocryst US Sales Co., LLC | 17 | $358 |
| Phathom Pharmaceuticals, Inc. | 8 | $356 |
| Amgen | 17 | $355 |
| Blueprint Medicines Corporation | 9 | $274 |
| Novartis | 12 | $244 |
| Kaleo, Inc. | 13 | $211 |
| Sunovion Pharmaceuticals Inc. | 3 | $142 |
| Teva Pharmaceuticals USA, Inc. | 6 | $130 |
| Octapharma USA, Inc. | 5 | $129 |
| Optinose US, Inc. | 8 | $128 |
| Boehringer Ingelheim | 6 | $100 |
| Aimmune Therapeutics, Inc. | 5 | $92 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $53 |
| Biocryst Pharmaceuticals, Inc. | 2 | $40 |
| Ionis Pharmaceuticals, Inc. | 1 | $39 |
| Lilly USA, LLC | 1 | $24 |
| Merck | 1 | $24 |
| Galderma Laboratories, L.p. | 1 | $23 |
| Bio Products Laboratory USA, Inc. | 1 | $20 |
| USWM, LLC | 1 | $17 |
| Alk-abello, Inc | 1 | $17 |
| AbbVie | 1 | $16 |
| Phadia US Inc. | 1 | $13 |
| Shire North American Group Inc | 1 | $12 |
How this compares
$13,743 in reported general payments places this provider in the 90th percentile of 54 allergy & immunology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Trumbull
- Robert DebernardoTrumbull$76
- Gavin SchwarzWest Hartford$302K
- Christina PriceNew Haven$237K
- Florence HsuNorth Haven$129K
- Jason LeeWest Hartford$30K
- Birur ChandraEast Haven$15K
- Prasad SrinivasanGlastonbury$14K
- Anita Kohli-PamnaniOrange$12K
- Jigisha MoroskyEnfield$12K
- Kenneth BackmanFairfield$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.